LONDON BROKER RATINGS: JPMorgan puts Haleon on negative catalyst watch
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:
----------
FTSE 100
----------
Barclays raises Croda price target to 3,500 (3,400) pence - 'overweight'
----------
Goldman Sachs cuts Autotrader price target to 561 (562) pence - 'buy'
----------
Goldman Sachs cuts Centrica price target to 215 (218) pence - 'buy'
----------
JPMorgan places Haleon on 'negative catalyst watch', cuts price target to 295 (315) pence - 'underweight'
----------
RBC cuts JD Sports Fashion price target to 90 (95) pence - 'sector perform'
----------
Citigroup raises J Sainsbury price target to 352 (346) pence - 'neutral'
----------
Jefferies raises Barratt Developments price target to 323 (303) pence - 'hold'
----------
Jefferies cuts Rentokil Initial price target to 370 (490) pence - 'buy'
----------
RBC raises Kingfisher price target to 375 (350) pence - 'outperform'
----------
FTSE 250
----------
RBC cuts Trustpilot price target to 300 (305) pence - 'outperform'
----------
Jefferies cuts Berkeley Group price target to 4,301 (4,517) pence - 'buy'
----------
RBC raises Keller price target to 3,510 (3,240) pence - 'outperform'
----------
Citigroup raises Bridgepoint price target to 480 (400) pence - 'buy'
----------
Jefferies raises Victrex price target to 760 (595) pence - 'hold'
----------
SMALL CAPS
----------
RBC raises Asos price target to 450 (400) pence - 'sector perform'
----------
JPMorgan raises Asos price target to 370 (330) pence - 'neutral'
----------
Jefferies cuts Crest Nicholson price target to 80 (107) pence - 'buy'
----------
RBC cuts 4basebio price target to 1,000 (1,400) pence - 'outperform'
----------
Comments and questions to newsroom@alliancenews.com
Copyright 2026 Alliance News Ltd. All Rights Reserved.
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
Why This Vanguard ETF Is One of the Best
6 ETFs To Diversify Away From AI
The Best AI Stocks to Buy Now